OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts’ evaluations of 12-month price targets offer additional insights, showcasing an average target of $14.6, with a high estimate of $17.00 and a low estimate of $13.00. This current average has increased by 12.31% from the previous average price target of $13.00.
Breaking Down Analyst Ratings: A Detailed Examination
The analysis of recent analyst actions sheds light on the perception of OptimizeRx by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| David Grossman | Stifel | Maintains | Buy | $13.00 | $13.00 |
| Constantine Davides | JMP Securities | Maintains | Market Outperform | $15.00 | – |
| Constantine Davides | JMP Securities | Announces | Market Outperform | $15.00 | – |
| David Grossman | Stifel | Maintains | Buy | $13.00 | $13.00 |
| Sean Dodge | RBC Capital | Maintains | Outperform | $17.00 | – |
Key Insights:
Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or ‘Lower’ their stance, it signifies their reaction to recent developments related to OptimizeRx. This insight gives a snapshot of analysts’ perspectives on the current state of the company.
Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from ‘Outperform’ to ‘Underperform’. These ratings convey expectations for the relative performance of OptimizeRx compared to the broader market.
Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of OptimizeRx’s stock. This comparison reveals trends in analysts’ expectations over time.
For valuable insights into OptimizeRx’s market performance, consider these analyst evaluations alongside crucial financial indicators….
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
